• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用 16SrRNA 测序研究微生物组与结直肠癌易感性的关系。

Study of the Relationship between Microbiome and Colorectal Cancer Susceptibility Using 16SrRNA Sequencing.

机构信息

Institute of Infection, Immunology and Tumor Microenvironment, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, Medical College, Wuhan University of Science and Technology, Wuhan 430065, China.

Department of Anesthesiology, The Third People's Hospital of Hubei Province, Wuhan 430030, China.

出版信息

Biomed Res Int. 2020 Jan 30;2020:7828392. doi: 10.1155/2020/7828392. eCollection 2020.

DOI:10.1155/2020/7828392
PMID:32083132
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7011317/
Abstract

A lot of previous studies have recently reported that the gut microbiota influences the development of colorectal cancer (CRC) in Western countries, but the role of the gut microbiota in Chinese population must be investigated fully. The goal of this study was to determine the role of the gut microbiome in the initiation and development of CRC. We collected fecal samples of 206 Chinese individuals: 59 with (group P), 54 with (group A), 51 with (group CC), and 42 (group HC).16S ribosomal RNA (rRNA) was used to compare the microbiota community structures among healthy controls, patients with polyp, and those with adenoma or colorectal cancer. Our study proved that intestinal flora, as a specific indicator, showed significant differences in its diversity and composition. Sobs, Chao, and Ace indexes of group CC were significantly lower than those of the healthy control group (CC group: Sobs, Chao, and Ace indexes were 217.3 ± 69, 4265.1 ± 80.7, and 268.6 ± 78.1, respectively; HC group: Sobs, Chao, and Ace indexes were 228.8 ± 44.4, 272.9 ± 58.6, and 271.9 ± 57.2, respectively). When compared with the healthy individuals, the species richness and diversity of intestinal flora in patients with colorectal cancer were significantly reduced: PCA and PCoA both revealed that a significant separation in bacterial community composition between the CC group and HC group (with PCA using the first two principal component scores of PC1 14.73% and PC2 10.34% of the explained variance, respectively; PCoA : PC1 = 14%, PC2 = 9%, PC3 = 6%). Wilcox tests was used to analyze differences between the two groups, it reveals that (=0.000356), (=0.000001), (=0.000796), (=0.013421), (=0.005642) were phyla with significantly different distributions between cases and controls. The proportion of microorganism composition is varying at different stages of colon cancer development: (52.14%) and (35.88%) were enriched in the healthy individuals; on the phylum level, the abundance of (52.14%-53.92%-52.46%-47.06%) and (35.88%-29.73%-24.27%-25.36%) is decreasing with the development of health-polyp-adenomas-CRC, and the abundance of (9.33%-12.31%-16.51%-22.37%) is increasing. PCA and PCOA analysis showed there was no significant ( < 0.05) difference in species similarity between precancerous and carcinogenic states. However, the composition of the microflora in patients with precancerous lesions (including patients with adenoma and polyp) was proved to have no significant disparity ( < 0.05). Our study provides insights into new angles to dig out potential biomarkers in diagnosis and treatment of colorectal cancer and to provide scientific advice for a healthy lifestyle for the sake of gut microbiota.

摘要

最近有很多研究报告称,肠道微生物群会影响西方国家结直肠癌(CRC)的发展,但必须充分研究中国人群肠道微生物群的作用。本研究旨在确定肠道微生物群在 CRC 的发生和发展中的作用。我们收集了 206 名中国个体的粪便样本:59 名患有 CRC(组 P),54 名患有腺瘤(组 A),51 名患有息肉(组 CC),42 名健康对照(组 HC)。使用 16S rRNA 比较健康对照组、息肉患者和腺瘤或结直肠癌患者的微生物群落结构。我们的研究证明,肠道菌群作为一种特定指标,其多样性和组成存在显著差异。CC 组的 Sobs、Chao 和 Ace 指数明显低于健康对照组(CC 组:Sobs、Chao 和 Ace 指数分别为 217.3±69、4265.1±80.7 和 268.6±78.1;HC 组:Sobs、Chao 和 Ace 指数分别为 228.8±44.4、272.9±58.6 和 271.9±57.2)。与健康个体相比,结直肠癌患者肠道菌群的物种丰富度和多样性明显降低:PCA 和 PCoA 均表明 CC 组和 HC 组之间细菌群落组成存在显著分离(PCA 采用 PC1 和 PC2 的前两个主成分得分,分别解释了 14.73%和 10.34%的方差;PCoA:PC1=14%,PC2=9%,PC3=6%)。Wilcox 检验分析两组间的差异,结果表明(=0.000356),(=0.000001),(=0.000796),(=0.013421),(=0.005642)在病例和对照之间的分布存在显著差异。微生物组成比例在结直肠癌发展的不同阶段发生变化:(52.14%)和(35.88%)在健康个体中富集;在门水平上,(52.14%-53.92%-52.46%-47.06%)和(35.88%-29.73%-24.27%-25.36%)的丰度随着健康-息肉-腺瘤-CRC 的发展而降低,(9.33%-12.31%-16.51%-22.37%)的丰度增加。PCA 和 PCOA 分析表明,癌前和致癌状态下的物种相似性没有显著差异(<0.05)。然而,我们发现癌前病变(包括腺瘤和息肉)患者的微生物群组成没有显著差异(<0.05)。本研究为挖掘结直肠癌诊断和治疗中的潜在生物标志物提供了新的角度,并为肠道微生物群的健康生活方式提供了科学建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7011317/7501d240e0b4/BMRI2020-7828392.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7011317/2fc660b15426/BMRI2020-7828392.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7011317/c40749a8a293/BMRI2020-7828392.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7011317/5141d5799dfc/BMRI2020-7828392.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7011317/f5506fc22959/BMRI2020-7828392.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7011317/31321dd80d7c/BMRI2020-7828392.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7011317/298ec0b84345/BMRI2020-7828392.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7011317/9c4b7934ad1c/BMRI2020-7828392.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7011317/7501d240e0b4/BMRI2020-7828392.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7011317/2fc660b15426/BMRI2020-7828392.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7011317/c40749a8a293/BMRI2020-7828392.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7011317/5141d5799dfc/BMRI2020-7828392.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7011317/f5506fc22959/BMRI2020-7828392.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7011317/31321dd80d7c/BMRI2020-7828392.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7011317/298ec0b84345/BMRI2020-7828392.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7011317/9c4b7934ad1c/BMRI2020-7828392.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7011317/7501d240e0b4/BMRI2020-7828392.009.jpg

相似文献

1
Study of the Relationship between Microbiome and Colorectal Cancer Susceptibility Using 16SrRNA Sequencing.使用 16SrRNA 测序研究微生物组与结直肠癌易感性的关系。
Biomed Res Int. 2020 Jan 30;2020:7828392. doi: 10.1155/2020/7828392. eCollection 2020.
2
Gut microbiota alterations in colorectal adenoma-carcinoma sequence based on 16S rRNA gene sequencing: A systematic review and meta-analysis.基于 16S rRNA 基因测序的结直肠腺瘤-癌序列中肠道微生物组的改变:系统评价和荟萃分析。
Microb Pathog. 2024 Oct;195:106889. doi: 10.1016/j.micpath.2024.106889. Epub 2024 Aug 26.
3
Characterizing the composition of intestinal microflora by gene sequencing.通过基因测序来描述肠道微生物群落的组成。
World J Gastroenterol. 2020 Feb 14;26(6):614-626. doi: 10.3748/wjg.v26.i6.614.
4
A comprehensive analysis of the microbiota composition and gene expression in colorectal cancer.对结直肠癌的微生物群落组成和基因表达进行全面分析。
BMC Microbiol. 2020 Oct 13;20(1):308. doi: 10.1186/s12866-020-01938-w.
5
Changes in gut microbiota and plasma inflammatory factors across the stages of colorectal tumorigenesis: a case-control study.结直肠肿瘤发生过程中肠道微生物群和血浆炎症因子的变化:一项病例对照研究。
BMC Microbiol. 2018 Aug 29;18(1):92. doi: 10.1186/s12866-018-1232-6.
6
The gut microbiota in conventional and serrated precursors of colorectal cancer.结直肠癌的常规和锯齿状前体中的肠道微生物群。
Microbiome. 2016 Dec 30;4(1):69. doi: 10.1186/s40168-016-0218-6.
7
Gut microbiota signatures in tissues of the colorectal polyp and normal colorectal mucosa, and faeces.结直肠息肉和正常结直肠黏膜组织及粪便中的肠道微生物群特征。
Front Cell Infect Microbiol. 2023 Jan 10;12:1054808. doi: 10.3389/fcimb.2022.1054808. eCollection 2022.
8
Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.结直肠腺瘤患者粪便代谢组学特征与肠道微生物群及结直肠癌发病早期事件相关。
mBio. 2020 Feb 18;11(1):e03186-19. doi: 10.1128/mBio.03186-19.
9
Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas.黏膜黏附菌的分子特征及其与结直肠腺瘤的关系。
Gut Microbes. 2010 May-Jun;1(3):138-47. doi: 10.4161/gmic.1.3.12360. Epub 2010 May 13.
10
Evolutionary biologic changes of gut microbiota in an 'adenoma-carcinoma sequence' mouse colorectal cancer model induced by 1, 2-Dimethylhydrazine.1,2-二甲基肼诱导的“腺瘤-癌序列”小鼠结直肠癌模型中肠道微生物群的进化生物学变化
Oncotarget. 2017 Jan 3;8(1):444-457. doi: 10.18632/oncotarget.13443.

引用本文的文献

1
Gut Mucosal Microbiome of Patients With Low-Grade Adenomatous Bowel Polyps.低级别腺瘤性肠息肉患者的肠道黏膜微生物群
Gastro Hep Adv. 2025 Apr 28;4(8):100687. doi: 10.1016/j.gastha.2025.100687. eCollection 2025.
2
Comprehensive analysis of transcriptome and microbiome in colorectal cancer with synchronous polyp patients.结直肠癌合并同步息肉患者的转录组和微生物组综合分析
Front Cell Infect Microbiol. 2025 Apr 17;15:1547057. doi: 10.3389/fcimb.2025.1547057. eCollection 2025.
3
Correlation analysis between quality characteristics and rhizosphere microorganisms of different wine grape varieties during their ripening phase.

本文引用的文献

1
Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation.对结直肠癌数据集的宏基因组分析确定了跨队列微生物诊断特征,并与胆碱降解有关。
Nat Med. 2019 Apr;25(4):667-678. doi: 10.1038/s41591-019-0405-7. Epub 2019 Apr 1.
2
Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer.基于粪便宏基因组的荟萃分析揭示了与结直肠癌具有特异性的全球微生物特征。
Nat Med. 2019 Apr;25(4):679-689. doi: 10.1038/s41591-019-0406-6. Epub 2019 Apr 1.
3
Microbiota transplantation: Targeting cancer treatment.
不同酿酒葡萄品种成熟期品质特性与根际微生物的相关性分析
Front Microbiol. 2025 Mar 26;16:1546323. doi: 10.3389/fmicb.2025.1546323. eCollection 2025.
4
Gut microbiome in colorectal cancer: metagenomics from bench to bedside.结直肠癌中的肠道微生物群:从实验室到临床的宏基因组学
JNCI Cancer Spectr. 2025 Apr 30;9(3). doi: 10.1093/jncics/pkaf026.
5
Differences in diversity and composition of mucosa-associated colonic microbiota in colorectal cancer and non-colorectal cancer in Indonesia.印度尼西亚结直肠癌与非结直肠癌患者中结肠黏膜相关微生物群的多样性和组成差异。
World J Gastroenterol. 2025 Feb 21;31(7):100051. doi: 10.3748/wjg.v31.i7.100051.
6
Global prevalence of Fusobacterium nucleatum and Bacteroides fragilis in patients with colorectal cancer: an overview of case reports/case series and meta-analysis of prevalence studies.结直肠癌患者中具核梭杆菌和脆弱拟杆菌的全球患病率:病例报告/病例系列概述及患病率研究的荟萃分析
BMC Gastroenterol. 2025 Feb 10;25(1):71. doi: 10.1186/s12876-025-03664-x.
7
Tumor microbiome: roles in tumor initiation, progression, and therapy.肿瘤微生物组:在肿瘤发生、发展和治疗中的作用。
Mol Biomed. 2025 Feb 8;6(1):9. doi: 10.1186/s43556-025-00248-9.
8
Interaction of human gut microbiota and local immune system in progression of colorectal adenoma (MIMICA-1): a protocol for a prospective, observational cohort study.结直肠腺瘤进展过程中人类肠道微生物群与局部免疫系统的相互作用(MIMICA-1):一项前瞻性观察队列研究方案
Front Oncol. 2025 Jan 6;14:1495635. doi: 10.3389/fonc.2024.1495635. eCollection 2024.
9
Dysregulation of saliva and fecal microbiota as novel biomarkers of colorectal cancer.唾液和粪便微生物群失调作为结直肠癌的新型生物标志物
Front Oncol. 2024 Dec 18;14:1498328. doi: 10.3389/fonc.2024.1498328. eCollection 2024.
10
Changes in Intestinal Microbiota and Their Relationship With Patient Characteristics in Colorectal Cancer.结直肠癌患者肠道微生物群的变化及其与患者特征的关系
Clin Med Insights Oncol. 2024 Dec 24;18:11795549241307632. doi: 10.1177/11795549241307632. eCollection 2024.
微生物群移植:以癌症治疗为目标。
Cancer Lett. 2019 Jun 28;452:144-151. doi: 10.1016/j.canlet.2019.03.010. Epub 2019 Mar 21.
4
Modulating the microbiome to improve therapeutic response in cancer.调节微生物组以改善癌症的治疗反应。
Lancet Oncol. 2019 Feb;20(2):e77-e91. doi: 10.1016/S1470-2045(18)30952-5.
5
Fusobacterium nucleatum - symbiont, opportunist and oncobacterium.具核梭杆菌——共生菌、机会致病菌和致癌菌。
Nat Rev Microbiol. 2019 Mar;17(3):156-166. doi: 10.1038/s41579-018-0129-6.
6
promotes colorectal tumorigenesis through the action of cytolethal distending toxin.通过细胞致死扩张毒素的作用促进结直肠肿瘤发生。
Gut. 2019 Feb;68(2):289-300. doi: 10.1136/gutjnl-2018-317200. Epub 2018 Oct 30.
7
A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of to Probiotics Populations, Based on Their Antagonistic Effect.一种基于益生菌拮抗作用的新型简单粪便生物标志物:/益生菌比值与结直肠癌。
Clin Chem. 2018 Sep;64(9):1327-1337. doi: 10.1373/clinchem.2018.289728. Epub 2018 Jun 18.
8
Association between and colorectal cancer: Progress and future directions.[具体内容]与结直肠癌之间的关联:进展与未来方向。 需注意,原文中“Association between and colorectal cancer”里“between”后面缺少具体内容。
J Cancer. 2018 Apr 18;9(9):1652-1659. doi: 10.7150/jca.24048. eCollection 2018.
9
The association of diet, gut microbiota and colorectal cancer: what we eat may imply what we get.饮食、肠道微生物群与结直肠癌的关联:我们所吃的可能暗示着我们所得到的。
Protein Cell. 2018 May;9(5):474-487. doi: 10.1007/s13238-018-0543-6. Epub 2018 Apr 30.
10
The Intestinal Microbiota in Colorectal Cancer.结直肠癌中的肠道微生物群。
Cancer Cell. 2018 Jun 11;33(6):954-964. doi: 10.1016/j.ccell.2018.03.004. Epub 2018 Apr 12.